Over 40 Presentations and Extensive Case Studies
Keynote Presentations
![]() |
The Tale of Two Manufacturing Platforms: What will the Future Hold? R. Andrew Ramelmeier, Ph.D. Vice President, Manufacturing, Process Sciences and Facilities BioMarin Pharmaceutical Inc. |
![]() |
From Clatter to Chorus: Reconciling the Voice of the Business with the Voice of the Customer William Botha Director of Manufacturing and QLP Baxter Bioscience |
Plenary Presentations
Latest update on biosimilars to help you plan for future market conditions
How Genentech used campaign frequency adjustments to reduce inventory and maximize plant output
|
Flexible Facilities: Enabling Efficiency with Process Improvements, Single Use and Other Technologies |
Operational Excellence: Enhancing Efficiencyand Quality |
|
|
Added Benefit: Site Tours to Amgen Fremont and BioMarin
According to a recent industry survey, the top three goals of most biopharmaceutical manufacturing companies are to improve in these areas:
Close on the heels of those top three are:
* Thomas, P., Pharmaceutical Manufacturing, Volume 8, Issue 6, p.22 (2009)
The BMD Summit is the best forum to gain the data and consultation you need to enable you and your interdisciplinary team members to achieve these important goals.
At this event you can choose to attend any presentations you wish from the tracks: Flexible Facilities and Operational Excellence. You will receive all of the presentation materials provided by the presenters from both tracks and you will have the chance to learn even more by seeing first-hand how leaders in the field put it all together if you opt for a in-person visit to BioMarin or Amgen's Fremont facility.
From the keynote presenters, you will learn how disposables and continuous processing can redefine the manufacturing platform of the future, and hear the latest best practices in lean manufacturing from Baxter Bioscience.
The US Naval nuclear submarine program is the gold standard for operational excellence programs. Hear experiences from a former nuclear submarine captain, Dennis Murphy, who is now the site head at Amgen's Fremont manufacturing facility, on bringing effective programs in learning from mistakes to continuous improvement in GMP manufacturing operations.
Hear the latest from FDA on CMC microbiology review and inspections for therapeutic biological proteins.
Copyright IBC Life Sciences, a part of Informa Life Sciences Group. | Phone: 800.390.4078 | Email: reg@ibcusa.com